LYRA vs TMUS · rev $1.5M vs P/E 19, rev $22.79B
Lyra Therapeutics Inc (LYRA) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
LYRA currently screens at market cap $14.4M. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the LYRA and TMUS stock pages for the full models.
Not investment advice.